N-(2-Acetylphenyl)Nonanamide
|
- $65 - $2232
- Product name: N-(2-Acetylphenyl)Nonanamide
- CAS: 1496050-19-1
- MF: C17H25NO2
- MW: 275.39
- EINECS:
- MDL Number:MFCD28991951
- Synonyms:N-(2-Acetylphenyl)Nonanamide;Nonanamide, N-(2-acetylphenyl)-;N-(2-Acetylphenyl)Nonanamide(WXC01699)
5 prices
Selected condition：
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 10mg
- 50mg
- 100mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number4102AQ
- Product descriptionN-(2-acetylphenyl)nonanamide
- Packaging100mg
- Price$278
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12139892
- Product descriptionN-(2-Acetylphenyl)nonanamide 95+%
- Packaging1g
- Price$743
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12139892
- Product descriptionN-(2-Acetylphenyl)nonanamide 95+%
- Packaging5g
- Price$2232
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA192633
- Product descriptionN-(2-Acetylphenyl)Nonanamide
- Packaging10mg
- Price$65
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA192633
- Product descriptionN-(2-Acetylphenyl)Nonanamide
- Packaging50mg
- Price$220
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 4102AQ | N-(2-acetylphenyl)nonanamide | 100mg | $278 | 2021-12-16 | Buy |
| Crysdot | CD12139892 | N-(2-Acetylphenyl)nonanamide 95+% | 1g | $743 | 2021-12-16 | Buy |
| Crysdot | CD12139892 | N-(2-Acetylphenyl)nonanamide 95+% | 5g | $2232 | 2021-12-16 | Buy |
| TRC | A192633 | N-(2-Acetylphenyl)Nonanamide | 10mg | $65 | 2021-12-16 | Buy |
| TRC | A192633 | N-(2-Acetylphenyl)Nonanamide | 50mg | $220 | 2021-12-16 | Buy |
Properties
Boiling point :444.4±28.0 °C(Predicted)
Density :1.021±0.06 g/cm3(Predicted)
pka :14.53±0.70(Predicted)
Density :1.021±0.06 g/cm3(Predicted)
pka :14.53±0.70(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|